Chametherpay-induced nausea and vomitting treat with Fire Needle

Fire Needle on Different time-piont to treating Chametherpay-induced nausea and vomitting

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100005252

Enrollment

Unknown

Registered

2021-08-28

Start date

2021-09-02

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chametherpay-induced nausea and vomitting

Interventions

control:none

Treatment B:Fire Needle

?? A:??

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ?Patients with malignant tumor diagnosed by pathology or cytology, or imaging combined with specific tumor markers; ?Patients previously received or ongoing highly emetogenic chemotherapy combinations containing cisplatin or cyclophosphamide + anthracycline (AC regimen)and ect.; ?The antiemetic drugs used were 5HT3 receptor antagonist or NK1 receptor; ?Patients generally in good condition with the Karnofasky score greater than or equal to 60 and the estimated survival more than or equal to 5 months. ?Aged 18 to 75; ?Patients without severe cardiovascular, liver, kidney, bone marrow insufficiency and abnormal coagulation function; ?Patients who signed the informed consent and were willing to accept the treatment.

Exclusion criteria

Exclusion criteria: ?Those who do not meet the above-mentioned inclusion criteria; ?Patients had been treated with acupuncture for other diseases during admission to pre-chemotherapy; ?Patients with nausea and vomiting due to brain metastases or limb metastases, or due to electrolyte disturbances and other systemic diseases such as severe diabetes; ?Patients with other severe infectious diseases, or with liver, kidney and cardiac insufficiency; ?Patients with mental retardation or a history of mental illness who are unable to conduct self-assessment; ?Patients who received radiotherapy during chemotherapy; ?Patients who cannot tolerate fire needles due to allergy, tension or other reasons.

Design outcomes

Secondary

Measure	Time frame
Simplified Nutritional Appetite Questionnaire;CTCAE V5.0;Hospital Anxiety and Depression Scale;	—

Primary

Measure	Time frame
MAT;No nausea rate;total control rate;Complete control rate;	—

Countries

China

Contacts

Public ContactLINGUAHUA

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

tcmlin-801@163.com13609021435

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026